Toremifene-associated endometrial polyp: A case report and review of the literature. |
Eun Hee Park, Sung Yun Bahng, Tae Sung Kim, Seong Taek Mun, Jib Kwang Chung, Seok Min Lee, So Young Jin |
1Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Seoul, Korea. 2Department of pathology, Soonchunhyang University College of Medicine, Seoul, Korea. |
|
Abstract |
Antiestrogens have been widely used in the treatment of breast cancer patients. Although tamoxifen is one of the most prevalent antiestrogens, some reported its hepatocarcinogenic effects and the long-term treatment may increase the risk of endometrial and gastrointestinal cancer. Toremifene is an interesting new antiestrogen and have a similar antitumor efficacy as tamoxifen, with less side-effect including less uterotrophic effect compared to tamoxifen, in mice. we report a case of endometrial polyp which were associated with toremifene use, in postmenopausal woman with breast cancer, with a brief review of literature. |
Key Words:
Toremifene, endometrial polyp |
|